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Background: There is limited data on elderly patients with severe aortic stenosis (AS) who do not undergo aortic valve replacement (AVR). We 
examined survival and predictors of mortality in unoperated elderly patients denied surgery for any of several reasons. 
Methods: We reviewed our hospital’s echocardiography database and identified all adult patients diagnosed with severe AS (defined as valve area 
<1.0 cm2) documented between Jan. 2006 and Dec. 2008. Demographic and clinical characteristics were reviewed. 
Results: A total of 448 patients were diagnosed with severe AS based on echocardiography, of whom 115 (26%; median age 74 yrs) underwent 
AVR. The 333 unoperated patients included 272 (82%) >75 yrs old (median age 84), of whom 166 (61%) had symptomatic AS; 254 (93%) had 
multiple comorbidities; 73 (27%) had undergone previous CABG; 106 (39%) had heart failure; 30 (11%) had angina pectoris alone; while 18 (7%) 
had syncope/presyncope. Median logistic EuroSCORE for unoperated patients was significantly lower among asymptomatic than symptomatic elderly 
patients (31% vs. 74%; p<0.001). At median follow-up of 2 yrs, 143 of the 272 elderly patients were dead compared with 16 of the 61 ≤75 yrs 
(52% vs. 26%; p<0.001). Independent predictors of mortality were age, history of CAD, diabetes, and poor right ventricular function from pulmonary 
hypertension. 
Conclusion: Prognosis of medically managed severe symptomatic AS in elderly patients is dismal, with only half surviving 2 years after being 
denied surgery. 
PATIENT CHARACTERISTICS: OPERATED/UNOPERATED PATIENTS
Variable
Age >75 years (n=272)
No. (%)
Age ≤75 years (n=61)
No. (%)
p Value*
Demographics
Age - years (IQR) 85 (81-89) 68 (63-71)) <0.001
Male Sex 103 (37.9%) 31 (50.8%) 0.062
Previous PCI 112 (41.2%) 39 (63.9%) <0.001
Previous CABG 73 (26.8%) 18 (29.5%) 0.672
Previous known valve disease 240 (88.2%) 57 (93.4%) <0.237
Risk Factors
Smoking 88 (32.4%) 32 (52.5%) 0.003
Hypertension 212 (77.9%) 44 (72.1%) 0.331
Diabetes mellitus 90 (33.1%) 30 (49.2%) 0.018
Dyslipidemia 139 (51.1%) 31 (50.8%) 0.968
Renal failure 67 (24.6%) 17 (27.9%) 0.599
Comorbidity
Previous MI 81 (29.8%) 16 (26.2%) 0.581
Carotid disease 43 (15.8%) 9 (14.8%) 0.838
Creatinine - mg/dL (IQR) 1.3 (0.9-1.7) 1.3 (1.0-1.7)) 0.838
Neurological dysfunction 46 (16.9%) 8 (13.1%) 0.467
COPD 51 (16.9%) 10 (16.4%) 0.922
Symptoms
NYHA
Class I 11 (8.1%) 2 (9.1%) 0.795
Class II 36 (26.5%) 8 (36.4%) 0.549
Class III 67 (49.3%) 8 (36.4%) 0.481
Class IV 22 (16.2%) 4 (18.2%) 0.940
Congestive heart failure 114 (42.1%) 18 (29.5%) 0.074
Medications
Aspirin 150 (55.4%) 24 (39.3%) 0.024
Beta blockers 136 (50.2%) 24 (39.3%) 0.126
ACE inhibitors/ARB 124 (45.8%) 22 (36.1%) 0.168
Statin 114 (42.1%) 32 (52.5%) 0.140
*P values were calculated with the chi-square test for the medians of age and lipids values, and Z-test or Fisher’s exact for two proportions (two-sided) between two group of patients, with and without medical 
history of MI, CAD, PAD, diabetes mellitus, stroke, renal failure or dialysis.
Percentages were calculated without missing data.
Abbreviations: ACE inhibitor=angiotensin-converting enzyme inhibitor; IQR=interquartile range; NYHA=New York Heart Association; PCI=percutaneous coronary intervention.
